Related Experiment Video
Updated: Feb 6, 2026

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
Research Progress on the Relationship between Atherosclerosis and Inflammation
Yuhua Zhu1, Xuemei Xian2, Zhenzhen Wang3
1Laboratory Animal Center, Xuzhou Medical University, Xuzhou 221004, Jiangsu, China. zhuyuhua116@126.com.
Insights
Atherosclerosis is a chronic inflammatory disease driven by inflammatory pathways. Targeting inflammation offers promising therapeutic strategies for cardiovascular disease treatment.
Area of Science:
- Cardiovascular Science
- Immunology
- Molecular Biology
Background:
- Atherosclerosis is a chronic inflammatory condition.
- Inflammation, mediated by cytokines and signaling pathways, drives plaque formation and rupture.
- This process can lead to acute cardiovascular events like heart attack and stroke.
Purpose of the Study:
- To review the role of inflammation and systemic inflammatory signaling in atherosclerosis.
- To examine the involvement of specific signaling pathways in atherosclerotic plaque development.
- To explore the potential of anti-inflammatory therapies for atherosclerosis.
Main Methods:
- Literature review of studies on atherosclerosis and inflammation.
- Analysis of inflammatory mediators, signaling pathways, and their impact on plaque biology.
- Discussion of current and future therapeutic strategies targeting inflammation.
Main Results:
- Inflammation is central to atherosclerosis pathogenesis, influencing plaque stability and thrombosis.
- Key inflammatory signaling pathways contribute significantly to atherosclerotic lesion formation.
- Inhibiting specific inflammatory targets shows potential for managing atherosclerosis.
Conclusions:
- Understanding the inflammatory basis of atherosclerosis is crucial for developing effective treatments.
- Targeting inflammatory pathways represents a promising therapeutic avenue for cardiovascular disease.
- Further research into anti-inflammatory strategies could significantly impact patient outcomes.
Abstract:
Atherosclerosis is a chronic inflammatory disease; unstable atherosclerotic plaque rupture, vascular stenosis, or occlusion caused by platelet aggregation and thrombosis lead to acute cardiovascular disease. Atherosclerosis-related inflammation is mediated by proinflammatory cytokines, inflammatory signaling pathways, bioactive lipids, and adhesion molecules. This review discusses the effects of inflammation and the systemic inflammatory signaling pathway on atherosclerosis, the role of related signaling pathways in inflammation, the formation of atherosclerosis plaques, and the prospects of treating atherosclerosis by inhibiting inflammation.
Related Concept Videos
Inflammation
Relationship Formation
Atherosclerosis III: Management
Atherosclerosis I: Introduction
Ending Relationships
Relationship Growth

